{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:15:28Z","timestamp":1773404128152,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"crossref","award":["BIO\/SA62\/14"],"award-info":[{"award-number":["BIO\/SA62\/14"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.vph.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T10:47:36Z","timestamp":1432205256000},"page":"172-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats"],"prefix":"10.1016","volume":"72","author":[{"given":"Jos\u00e9-\u00c1ngel","family":"Garc\u00eda-Pedraza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Luisa","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2015.05.003_bb0005","article-title":"The role of the kidney and the sympathetic nervous system in hypertension","author":"Thomas","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.vph.2015.05.003_bb0010","first-page":"925","article-title":"Renal denervation","volume":"57","author":"Id","year":"2013"},{"key":"10.1016\/j.vph.2015.05.003_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1113\/expphysiol.2004.029215","article-title":"Dynamic analysis of patterns of renal sympathetic nerve activity: implications for renal function","volume":"90","author":"DiBona","year":"2005","journal-title":"Exp Physiol"},{"key":"10.1016\/j.vph.2015.05.003_bb0020","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/hc1102.105261","article-title":"Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease","volume":"105","author":"Zoccali","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.05.003_bb0025","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.HYP.0000260251.11364.1f","article-title":"Renal sympathetic neuroeffector function in renovascular and angiotensin II-dependent hypertension in rabbits","volume":"49","author":"Burke","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2015.05.003_bb0030","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fphys.2012.00284","article-title":"Sympathetic regulation of vascular function in health and disease","volume":"3","author":"Bruno","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.vph.2015.05.003_bb0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/FJC.0000000000000064","article-title":"The sympathetic nervous system as a target for the treatment of hypertension and cardiometabolic diseases","volume":"63","author":"Sorota","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0040","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0000000000000210","article-title":"Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?","volume":"32","author":"de Beus","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.vph.2015.05.003_bb0045","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1476-5381.1994.tb17147.x","article-title":"Inhibitory 5-hydroxytryptamine receptors involved in pressor effects obtained by stimulation of sympathetic outflow from spinal cord in pithed rats","volume":"113","author":"Mor\u00e1n","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0050","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1111\/j.1476-5381.1995.tb15143.x","article-title":"Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat","volume":"116","author":"Villalon","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bjp.0706216","article-title":"Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat","volume":"145","author":"Garc\u00eda","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2010.06.013","article-title":"Pharmacological profile of 5-hydroxytryptamine-induced inhibition on the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats","volume":"643","author":"Mor\u00e1n","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2013.05.045","article-title":"Peripheral 5-HT1D and 5-HT7 serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats","volume":"714","author":"Garc\u00eda-Pedraza","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.111.004697","article-title":"Serotonin and blood pressure regulation","volume":"64","author":"Watts","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.vph.2015.05.003_bb0075","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.bjp.0701714","article-title":"Characterization of prejunctional 5-HT1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rat","volume":"123","author":"Mor\u00e1n","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00210-007-0179-1","article-title":"Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors\/mechanisms involved and therapeutic implications","volume":"376","author":"Villal\u00f3n","year":"2007","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1476-5381.1987.tb11338.x","article-title":"Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion","volume":"92","author":"Ireland","year":"1987","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0090","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1476-5381.1995.tb16651.x","article-title":"Evidence that 5-HT1D receptors mediate inhibition of sympathetic ganglionic transmission in anaesthetized cats","volume":"116","author":"Jones","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0095","first-page":"H219","article-title":"Continuous measurement of renal blood flow changes to renal nerve stimulation and intra-arterial drug administration in rat","volume":"234","author":"Fink","year":"1978","journal-title":"Am J Physiol"},{"key":"10.1016\/j.vph.2015.05.003_bb0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-2999(97)01006-6","article-title":"Renal vasoconstrictor response to 5-hydroxytryptamine in the in situ autoperfused rat kidney: involvement of angiotensin II and the 5-HT2 receptor activation","volume":"330","author":"Mor\u00e1n","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2008.06.106","article-title":"Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat","volume":"592","author":"Mor\u00e1n","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2011.03.006","article-title":"Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats","volume":"659","author":"Restrepo","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2014.02.043","article-title":"The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats","volume":"731","author":"Garc\u00eda-Pedraza","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2009.08.026","article-title":"Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of l-NAME hypertensive rats","volume":"620","author":"Mor\u00e1n","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2004.04.029","article-title":"The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig","volume":"493","author":"Pullar","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0130","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1476-5381.1990.tb14151.x","article-title":"Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo","volume":"101","author":"Rees","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pharmthera.2004.08.005","article-title":"Functions of 5-HT2A receptor and its antagonists in the cardiovascular system","volume":"104","author":"Nagatomo","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.vph.2015.05.003_bb0140","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tips.2008.06.009","article-title":"5-Hydroxytryptamine and cardiovascular regulation","volume":"29","author":"Ramage","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.vph.2015.05.003_bb0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2011.09.165","article-title":"In-vivo evidence of a role for nitric oxide in regulating the activity of the norepinephrine transporter","volume":"671","author":"Simaan","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1440-1681.2002.03693.x","article-title":"Selective peripheral regulation of noradrenaline and adrenaline release by nitric oxide","volume":"29","author":"Elayan","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.vph.2015.05.003_bb0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00168629","article-title":"Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex","volume":"353","author":"B\u00fchlen","year":"1996","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00169451","article-title":"Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT1D subtype","volume":"342","author":"Molderings","year":"1990","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0165","first-page":"11","article-title":"Heterogeneity of presynaptic serotonin receptors on sympathetic neurones in blood vessels","volume":"28","author":"G\u00f6thert","year":"1991","journal-title":"Blood Vessels"},{"key":"10.1016\/j.vph.2015.05.003_bb0170","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF00168555","article-title":"5-Hydroxytryptamine 5-HT1D receptors mediating inhibition of cyclic AMP accumulation in Madin\u2013Darby canine kidney (MDCK) cells","volume":"352","author":"Schoeffter","year":"1995","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0175","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0031-6997(25)06783-3","article-title":"International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.vph.2015.05.003_bb0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0165-6147(98)01228-0","article-title":"5-HT1-like receptors: a time to bid goodbye","volume":"19","author":"Saxena","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.vph.2015.05.003_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1124\/pr.54.1.43","article-title":"Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors","volume":"54","author":"Boehm","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.vph.2015.05.003_bb0190","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.bjp.0705489","article-title":"Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A\/5B receptors","volume":"140","author":"S\u00e1nchez-Lopez","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.vph.2015.05.003_bb0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1440-1681.1999.03006.x","article-title":"Activation of vascular smooth muscle K+ channels by endothelium-derived relaxing factors","volume":"26","author":"Waldron","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.vph.2015.05.003_bb0205","doi-asserted-by":"crossref","first-page":"H1072","DOI":"10.1152\/ajpheart.00072.2007","article-title":"Contributions of endothelium-derived relaxing factors to control of hindlimb blood flow in the mouse in vivo","volume":"293","author":"Fitzgerald","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.vph.2015.05.003_bb0210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/STROKEAHA.108.516104","article-title":"Presynaptic prostaglandin E2 EP1-receptor facilitation of cerebral nitrergic neurogenic vasodilation","volume":"40","author":"Jadhav","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2015.05.003_bb0215","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/hr.2010.48","article-title":"Altered function of nitrergic nerves inhibiting sympathetic neurotransmission in mesenteric vascular beds of renovascular hypertensive rats","volume":"33","author":"Koyama","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1016\/j.vph.2015.05.003_bb0220","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.atherosclerosis.2008.06.008","article-title":"Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease","volume":"202","author":"Luksha","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2015.05.003_bb0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vph.2009.02.005","article-title":"A potent and nitric oxide-dependent hypotensive effect induced in rats by semi-purified fractions from Maytenus ilicifolia","volume":"51","author":"Crestani","year":"2009","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0230","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1098\/rstb.1981.0108","article-title":"Prostacyclin: its biosynthesis, actions and clinical potential","volume":"294","author":"Moncada","year":"1981","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vph.2015.05.003_bb0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bjp.0705264","article-title":"5-HT decreases contractile and electrical activities in lymphatic vessels of the guinea-pig mesentery: role of 5-HT 7-receptors","volume":"139","author":"Chan","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000341911","article-title":"The cyclooxygenase and nitric oxide synthesis\/pathways mediate the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats","volume":"90","author":"Restrepo","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/j.vph.2015.05.003_bb0245","doi-asserted-by":"crossref","first-page":"H1438","DOI":"10.1152\/ajpheart.01020.2011","article-title":"Sympathetic activation and nitric oxide function in early hypertension","volume":"302","author":"Gamboa","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.vph.2015.05.003_bb0250","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1476-5381.1995.tb13299.x","article-title":"Canine renovascular responses to sumatriptan and 5-carboxamidotryptamine: modulation through endothelial 5-HT1-like receptors by endogenous nitric oxide","volume":"114","author":"Whiting","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0255","first-page":"H2246","article-title":"5-Hydroxytryptamine-induced NO-dependent relaxation in isolated strips of monkey popliteal lymph nodes","volume":"268","author":"Mizuno","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.vph.2015.05.003_bb0260","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1159\/000075806","article-title":"Endothelium-dependent relaxant responses to selective 5-HT(1B\/1D) receptor agonists in the isolated middle cerebral artery of the rat","volume":"40","author":"Hansen-Schwartz","year":"2003","journal-title":"J Vasc Res"},{"key":"10.1016\/j.vph.2015.05.003_bb0265","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1248\/bpb.b13-00344","article-title":"5-Hydroxytryptamine and its receptors in systemic vascular walls","volume":"36","author":"Machida","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.vph.2015.05.003_bb0270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mvr.2014.08.002","article-title":"Effects of intracerebroventricular injections of 5-HT on systemic vascular resistances of conscious rats","volume":"95","author":"Davisson","year":"2014","journal-title":"Microvasc Res"},{"key":"10.1016\/j.vph.2015.05.003_bb0275","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2006.03.020","article-title":"The nitric oxide synthesis\/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats","volume":"537","author":"Garc\u00eda","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.vph.2015.05.003_bb0280","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(01)02645-2","article-title":"5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase","volume":"909","author":"Hou","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.vph.2015.05.003_bb0285","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00424.2007","article-title":"Nitric oxide deficiency in chronic kidney disease","volume":"294","author":"Baylis","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.vph.2015.05.003_bb0290","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3565(25)38716-1","article-title":"The effects of NG-nitro-l-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs","volume":"269","author":"Egi","year":"1994","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T01:55:37Z","timestamp":1748397337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":58,"alternative-id":["S1537189115001056"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2015.05.003","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}